The latest biotech news

News and Trends 26 Oct 2021

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

Last week, the French vaccine maker Valneva announced promising phase III trial results of its inactivated Covid-19 vaccine: a well-established technology that could confer broader immunity to the virus than shots currently on the market. Valneva’s vaccine candidate consists of a killed or ‘inactivated’ version of SARS-CoV-2, the virus responsible for Covid-19. The vaccine was […]

October 26, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 22 Oct 2021

Gene-Edited T Cell Therapy Players Battle Safety Doubts

Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused all clinical development following the detection of an unexpected genetic change in a clinical trial. Industry experts see these events as a reality check for the nascent field. Off-the-shelf treatments that use genetically engineered T cells to treat diseases suffered […]

October 22, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 19 Oct 2021

Biotech VCs Face Funding Bulge Amid Struggling Stock Markets

Despite volatile biotech stocks limiting options for exit, Sofinnova Partners’ latest €472M fund highlights ballooning European venture capital and its growing focus on early-stage biotech investments. Biotech fundraising broke records in 2020 as the Covid-19 pandemic swept the globe. This year seems set to continue biotech’s winning streak in private fundraising. One example is a […]

October 19, 2021 - 5 minutesmins - By Jonathan Smith

oxford nanopore technologies genomics sequencing

News and Trends 15 Oct 2021

Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

Oxford Nanopore Technologies, until recently one of very few unicorns in the European biotech industry, had a stellar IPO on the London Stock Exchange late last month. This is ushering in a whole new generation of DNA sequencing, genetics research, and diagnostics. During the first day of the IPO, which bagged the firm over €400M […]

October 15, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 12 Oct 2021

The Top European Biotech Investment Rounds in September

Initial public offerings by European biotech companies were hot in September, and companies developing technologies including sequencing and bioinformatics received big private and public investments. Last month, European and Israeli biotech companies raised over €1.5B in 42 deals, which included initial public offerings (IPOs) and private financing rounds. This was more than triple the total […]

October 12, 2021 - 4 minutesmins - By Jonathan Smith

Switzerland longevity geroscience foundation

News and Trends 11 Oct 2021

Longevity Foundation to Fund Geroscience Research with €860M

The newly-created Longevity Science Foundation aims to extend the human lifespan to more than 120 years by channeling over €860M ($1B) into early-stage geroscience research in the next decade. Experts say that’s a worthy if complex goal. Based in Zug, Switzerland, the Longevity Science Foundation will prioritize four areas of research: personalized medicine, therapeutics, artificial […]

October 11, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 7 Oct 2021

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery

Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts to use artificial intelligence to fuel drug discovery, with global tech investors often taking the lead. The Oxford, UK-based company Exscientia has one of the most mature artificial intelligence (AI)-focused drug discovery pipelines, alongside companies like BenevolentAI in the UK, […]

October 7, 2021 - 5 minutesmins - By Mark Zipkin

News and Trends 4 Oct 2021

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

Although most gene therapy still relies on non-infectious viral vectors for delivery, a recent venture financing round for the Swiss company Anjarium Biosciences has shone the spotlight on alternative vectors, including lipid nanoparticles and electric pulses. Last month, Anjarium Biosciences raised €51M (CHF55.5M) in a Series A financing round to advance its gene delivery system […]

October 4, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 1 Oct 2021

Novo Nordisk Foundation Pumps €85M into Carbon Capture Research

As pressure mounts to tackle climate change, the Danish Novo Nordisk Foundation has granted €84.7M to the world’s first research institution dedicated to capturing carbon dioxide from the air and harnessing the gas as a raw material. The new Novo Nordisk Foundation CO2 Research Center has the mission to efficiently capture, store, and recycle the […]

October 1, 2021 - 6 minutesmins - By Anita Chakraverty

News and Trends 24 Sep 2021

Breath Testing To Be Tapped by UK Pioneer with €50M Fundraising

After years of under-fulfilled promise, breath tests for cancer, liver disease, and respiratory conditions appear to be taking off with UK biotech Owlstone Medical raking in almost €50M (£42M) in an oversubscribed Series D funding round. The round, whose original target was about €43M, was led by the Hong Kong-based Horizons Ventures and was joined […]

September 24, 2021 - 3 minutesmins - By Victor Kotsev

antibiotic resistance investment funding amr

News and Trends 21 Sep 2021

Europe’s Antibiotic Investments Stagnate As Resistance Crisis Looms

Despite the urgent danger of antibiotic resistance, investments into European biotech antibiotic players have remained flat. However, growing regulatory and societal awareness could spell fresh investments in the coming years. Over the last decade, pressure has been mounting on healthcare systems as infectious microbes become harder and harder to fight with antibiotics. Some strains of […]

September 21, 2021 - 7 minutesmins - By Jonathan Smith

News and Trends 17 Sep 2021

Cell Therapy Firm Raises €64M to Revolutionize Manufacturing

This week’s €64M Series B fundraise from the French firm TreeFrog Therapeutics is the latest in a thriving movement to make the manufacture of gene and cell therapies easier and cheaper. Cell and gene therapies offer huge potential to treat a wide range of diseases including cancer, neurological, and genetic diseases. They have even shown […]

September 17, 2021 - 8 minutesmins - By Helen Albert

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

Gene-Edited T Cell Therapy Players Battle Safety Doubts

Biotech VCs Face Funding Bulge Amid Struggling Stock Markets

Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

The Top European Biotech Investment Rounds in September

Longevity Foundation to Fund Geroscience Research with €860M

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

Novo Nordisk Foundation Pumps €85M into Carbon Capture Research

Breath Testing To Be Tapped by UK Pioneer with €50M Fundraising

Europe’s Antibiotic Investments Stagnate As Resistance Crisis Looms

Cell Therapy Firm Raises €64M to Revolutionize Manufacturing

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!